PFE · News · 20260824N

COVID Product Demand Decline

PFIZER INC · 2026-08-24 · Importance 18 · Surprise 24

Third-party reporting states that Pfizer’s COVID-related revenue is declining. The decline is being balanced by sales of core products, according to the report. This indicates continued demand normalization for Pfizer’s COVID portfolio while newer products and pipeline programs become more important to the company’s growth mix.

Key facts